GpIba, a subunit of the von Willebrand factor receptor, functions during blood clotting to promote platelet adhesion and activation. GpIba is widely expressed, is positively regulated by c-Myc and is essential for the promotion of c-Myc-mediated chromosomal instability. We now show that GpIba is also a classical oncoprotein in which its deregulated expression leads to transformation, reduced growth factor requirements, increased resistance to apoptosis, and, in primary cells, p53-dependent senescence. Finally, GpIba also promotes double-stranded DNA breaks, and induces profound nuclear dysmorphology, indicating that, in addition to its direct transforming function, it displays genotoxicity at several distinct levels. These findings identify novel functions for GpIba and pathways through which c-Myc mediates transformation and global genomic destabilization.
Introduction c-Myc promotes transformation and alterations in proliferation, apoptosis and genomic instability (GI) in association with the deregulation of hundreds of direct target genes (Nesbit et al., 2000; Dang et al., 2006) . The degree to which these properties are affected varies according to the levels of c-Myc, the cell type and the expression of other modifying genes (Grandori et al., 2000; Zhou and Hurlin, 2001) .
Despite this molecular complexity, a number of c-Myc target genes are themselves transforming and/or able to recapitulate other c-Myc phenotypes (reviewed in Rogulski et al., 2005b) . One such target, MT-MC1, encodes a nuclear protein with the unique ability to reproduce multiple c-Myc functions (Yin et al., 2002; Rothermund et al., 2005) . Surprisingly, MT-MC1 deregulates o50 genes most of which are also direct c-Myc targets (Rogulski et al., 2005b) . These findings suggest that MT-MC1-regulated genes comprise a 'privileged' subset of c-Myc targets with a disproportionate role in mediating c-Myc phenotypes.
One common c-Myc and MT-MC1 target is GpIba, a membrane glycoprotein thought to be expressed largely by megakaryocytes and platelets. GpIba is a subunit of the von Willebrand factor receptor (vWFR) and is necessary for platelet adhesion and activation (Canobbio et al., 2004) . Megakaryocytes also undergo endomitosis, which results in the acquisition of polyploidy (Ravid et al., 2002) . Because changes in GpIba expression also affect polyploidization (Kanaji et al., 2004) , and because c-Myc and MT-MC1 overexpression promotes tetraploidy and aneuploidy (Li and Dang, 1999; Yin et al., 1999 Yin et al., , 2002 , we previously investigated the relationship among these proteins in promoting GI. We observed that GpIba is actually widely expressed, is necessary for the induction of c-Myc-and MT-MC1-mediated tetraploidy and that its singular overexpression is sufficient to promote tetraploidy in many cell types .
Given the dramatic influence of GpIba on GI and the close relationship between aneuploidy and neoplasia (Weaver and Cleveland, 2006) , we have investigated GpIba's role in transformation. We report here that GpIba is a classic oncoprotein by virtue of its ability to transform, promote growth and inhibit apoptosis. The induction of tetraploidy by GpIba, while not a prerequisite for transformation, also accelerates in vivo tumorigenesis. Furthermore, GpIba promotes senescence and widespread nuclear damage in primary cells via p53. Together, these studies establish the existence of potent transforming, growth altering and genome destabilizing properties of GpIba that can explain many c-Myc phenotypes.
Results

GpIba is transforming
Because GpIba mediates tetraploidy by c-Myc and MT-MC1 , we asked if it also possess other oncoprotein-like properties. Because c-Myc and MT-MC1 transform rat fibroblasts, alter their growth and survival, and promote GI (Yin et al., 2002; Rothermund et al., 2005) , we initially used these to determine the consequences of GpIba overexpression. As previously shown , control Rat1a cells arrested in G 2 /M following mitotic arrest, whereas Rat1a-GpIba cells became tetraploid for at least 5-6 weeks, thus allowing a comparison between them and diploid cells for a variety of relevant properties (Figures 1a and b) .
Both diploid and tetraploid cells formed soft agar colonies with equivalent efficiencies (Figures 1c and d) . When several randomly chosen colonies from each group were picked and briefly expanded, their genomic DNA content was found to be indistinguishable from that of the starting cells (not shown). Thus, ectopic GpIba expression confers anchorage-independent growth and GI to Rat1a cells although tetraploidy is not necessary for this property nor does it significantly alter it.
Rat1a-GpIba cells were also tumorigenic. As seen in Figure 1e , nude mice inoculated with both diploid and tetraploid Rat1a-GpIba cells developed tumors, although the latter appeared more rapidly and reached a larger size. Thus, in vivo tumorigenesis was influenced by initial ploidy.
Surprisingly, single cell suspensions from tetraploid Rat1a-GpIba tumors were largely diploid (Figures 2a-d ), although they expressed high levels of GpIba (Figure 2e ). Upon repeat exposure to colcemid, these cells again became tetraploid (Figures 2f and g ). This suggested that tumors maintained in vivo were under selective pressure to eliminate tetraploid genomes despite continuing to express and respond to GpIba.
We next compared the rates of in vivo tumor growth among four animal groups. The first two were inoculated with the diploid or tetraploid Rat1a-GpIba cells described in Figure 1e . The third group was inoculated with tumor-derived tetraploid-diploid revertant cells. The fourth group was identical to the third except that (Rothermund et al., 2005; Li et al., 2007) . Immunoblots were performed with mAbs directed against the myc epitope (top) or b-tubulin (bottom), which served as a loading control. (b) Cell cycle analyses. Cells were harvested in log-phase growth, after a 16 h exposure to colcemid, or 2 weeks after an initial 16 h exposure to colcemid. Nuclei were stained with propidium iodide and analysed by flow cytometry (Yin et al., 2002) . (c) Anchorage-independent growth of Rat1a-GpIba cells. Equivalent numbers of cells were plated in soft agar and colonies enumerated in triplicate wells 12-14 days later (Rothermund et al., 2005 
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Y Li et al the cells were again rendered tetraploid just prior to inoculation. The slow growth of tumors in the first group and rapid growth in the second were again observed. Most interestingly, tumors in both the third and fourth groups arose even more rapidly than those from the second group, with those in the latter group again reverting to diploidy (not shown). Tetraploid Rat1a-GpIba cells thus acquire a distinct in vivo growth advantage relative to their diploid counterparts, most likely as a consequence of their initial GI. However, whereas the aggressive tumorigenic phenotype is selected for upon subsequent in vivo growth, tetraploidy per se is lost.
GpIba promotes growth and survival
To determine whether GpIba also affected growth and survival, we examined the proliferative and apoptotic responses of the above Rat1a cells. Similar experiments were also performed in GpIba-overexpressing, interleukin-3 (IL-3)-dependent 32D murine myeloid cells or in 32D cells depleted of endogenous GpIba . As shown in Figure 3a , Rat1a-GpIba cells grew modestly faster and reached a higher saturation density than control cells under standard conditions (10% fetal bovine serum, FBS), a finding that was even more pronounced in 1% serum (Figure 3b ). Similar behavior was seen in 32D GpIba cells under limiting IL-3 concentrations (Figure 3c ). In contrast, growth suppression was seen in 32D cells depleted of endogenous GpIba (Figure 3d ). To examine apoptosis, Rat1a and 32D cells were deprived of serum or IL-3, respectively. Under these conditions, GpIba-overexpressing cells showed enhanced survival (Figures 3e and f) whereas GpIbadepleted 32D cells showed accelerated apoptosis (Figure 3g ). Thus, depending upon the environment, GpIba strongly influences the sensitivities of established cell lines to both proliferative and survival signals. Nude mice were inoculated with diploid or tetraploid Rat1a-GpIba cells as described in Figure 1e and served as controls. A third group was inoculated with diploid cells derived from a tetraploid-diploid revertant tumor (b). Finally, a fourth group was inoculated with tetraploid-diploid tumor-derived cells rendered tetraploid a second time by exposure to colcemid (g).
Transformation by GpIba Y Li et al GI in primary cells occurs at several levels and is associated with p53-and pRb-dependent mitotic checkpoint induction and premature senescence In established cell lines, GpIba-mediated GI usually occurs after mitotic spindle inhibition but can also arise spontaneously Figure 1b) . In contrast, GI is rarely observed in GpIba-overexpressing primary cells, where even colcemid treatment results in only modest levels of transient tetraploidy . This suggests that primary cells possess mitotic checkpoints that prevent further propagation upon acquiring tetraploid genomes (Andreassen et al., 2001) . Because the p53 pathway is inactivated in most established cell lines, p53 participates in the mitotic checkpoint and tetraploid cells with intact p53 are at a proliferative disadvantage (Meek, 2000; Fujiwara et al., 2005) , we examined the relationship between this tumor suppressor and GpIba. We used shRNA to ablate endogenous p53 in GpIba-expressing primary human fetal fibroblasts (HFFs; Li et al., 2007) . The experiment in (a) was repeated except that cultures were switched to 1% FBS the day after initial seeding. (c) 32D-GpIba and 32D-vector cells were seeded as in (a) and counted in triplicate at the indicated times. (d) 32D cells stably expressing a GpIba shRNA, or control 32D-vector cells, have been previously described . Growth kinetics in limiting interleukin-3 (IL-3) concentrations (50 pg ml À1 ) were monitored as in (c). (e) Rat1a-GpIba and Rat1a-vector cells were grown to approximately 50% confluency and then deprived of serum (Nesbit et al., 2000) . At the times indicated, viable cell counts were determined in triplicate. (f) 32D-GpIba and 32D-vector cells were re-plated in medium lacking IL-3 and then enumerated as described in (e). (g) 32D-shGpIba and 32D-vector cell apoptotic profiles following IL-3 deprivation.
Transformation by GpIba Y Li et al cells also arrested in G 2 /M, although a small subpopulation developed unstable tetraploidy that quickly disappeared following colcemid withdrawal (Figure 4d ). In contrast, combined GpIba overexpression and p53 knockdown led to high levels of stable tetraploidy. 
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Because HFFs are resistant to serum deprivationmediated apoptosis (Rogulski et al., 2005a) , we were unable to study this property. However, we were able to determine effects on proliferation. As previously shown (Bartkova et al., 2006; Di Micco et al., 2006) , p53 knockdown in HFFs enhanced proliferation (Figure 4f) . In contrast to established lines (Figures 3a-d) , HFFGpIba cells actually grew significantly slower than controls, although this was reversed following p53 inactivation (Figure 4f) . The impaired proliferation of HFF-GpIba cells could not be explained by increased apoptosis (not shown). These findings suggest that ploidy and proliferation differences in response to GpIba overexpression are p53 dependent.
A major antitumor defense of primary cells involves oncogene-induced senescence, particularly in response to genomic damage incurred during DNA hyperreplication (Bartkova et al., 2006; Di Micco et al., 2006) . Both p53 and pRb appear to be central to the senescence process by restricting malignant progression (Sedivy, 2007) . Because both the growth promoting and tetraploid-inducing activities of GpIba in HFFs required p53 (Figures 4b-f) , GpIba functions as a classic transforming oncoprotein in immortalized cells (Figure 1) , and GpIba induces p53 (Figure 4a ), we asked whether the impaired growth of HFF-GpIba cells might be a sign of senescence. We therefore examined the four lines described in Figure 4a for expression of senescenceassociated b-galactosidase (SA-b-gal) (Dimri et al., 1995) . In contrast to HFF-GpIba-shp53 cells, those with intact p53 expressed SA-b-gal and showed the flattened morphology typical of senescence (Figure 4g ; Supplementary Figure 1a) . Additional evidence of senescence was obtained by showing high levels of the pRb regulator p16
INK4a (Serrano et al., 1997; Bartkova et al., 2006;  Figure 4h ; Supplementary Figure 1b) . In contrast, resumption of proliferation following p53 suppression was associated with p16
INK4a suppression. The above cell lines were next examined for g-H2AX foci, a marker of double-stranded DNA breaks (DSBs) (Sedelnikova et al., 2004) . Although often used as a marker of senescence, g-H2AX foci are not specific and can result from other forms of genotoxic stress (Sedelnikova et al., 2004) . In contrast to SA-b-gal and p16
INK4a , g-H2AX foci were observed in HFF-GpIba cells irrespective of p53 status (Figure 4i; Supplementary  Figure 1c) . Because HFF-GpIba þ shp53 proliferate normally, express neither SA-b-gal nor p16
INK4a
, show normal morphology and are nonapoptotic, g-H2AX foci likely reflect ongoing DNA damage. Elevated basal levels of p53 supported this interpretation as did the finding that a large fraction of HFF-GpIba þ shp53 cells contained multiple nuclei and micronuclei (Figures 4a and i) .
To further understand the interrelationship between GpIba and p53 in promoting tetraploidy and senescence, we examined individual 4 0 6-diamidino-2-phenyl indole (DAPI)-stained cells from the above HFF groups by fluorescence microscopy. Unlike population-based assays (Figures 4b-e) , these were designed to assess the numerical and morphological variations among individual nuclei. Of note was that HFF control cells and HFF shp53 cells generally contained only single nuclei of uniform size and shape (Figure 5a ). In contrast, approximately 15% of HFF-GpIba cells contained two nuclei suggesting a failure of cytokinesis (Figures 5a and b) . Furthermore, when endogenous p53 was disabled, a >2-fold increase in multi-nucleated cells was seen, often accompanied by marked structural changes. Micronuclei and chromosomal bridging were also commonly observed in these latter cells (Figure 5a ; and Supplementary Figure 2) . Thus, despite GpIba's apparent minimal effect on HFF ploidy, these cells contain significant nuclear abnormalities, which increase markedly following p53 checkpoint compromise.
GpIba target genes
The cytoplasmic tail of GpIba interacts with proteins such as 14-3-3z and filamin, thus influencing cell signaling and actin cytoskeleton function, respectively (Asazuma et al., 1997; Kanaji et al., 2004; Dai et al., 2005; Ozaki et al., 2005) . However, the transcriptional consequences of this are unclear. Because the identification of its target genes might address how GpIba mediates the novel properties described here, we compared the gene expression profiles of Rat1a-vector cells, to diploid and tetraploid Rat1a-GpIba cells. We selected culture conditions that minimized growth and survival differences, thus ensuring that any transcript disparities would reflect GpIba expression only. A total of 223 transcripts were differentially expressed between control Rat1a-vector and diploid Rat1a-GpIba cells (84 upregulated and 139 downregulated in the former cells; Supplementary Figure 3 ). We were able to assign identities to 162 of these transcripts (56 upregulated and 102 downregulated; Supplementary Table 1) . We next compared the transcriptional profiles of Rat1a-vector and tetraploid Rat1a-Gpiba cells and identified 210 differentially expressed transcripts (88 upregulated and 122 downregulated in the former cells). We were able to assign identities to 155 of these transcripts (64 upregulated and 91 downregulated; Supplementary Table 2) .
A comparison between the two data sets (diploid Rat1a-Gpiba vs tetraploid Rat1a-GpIba) showed overlap of 163 transcripts (60.4%), thus suggesting that these were common, ploidy-independent targets (Supplementary Figure 3a ; Supplementary Tables 1 and 2 ). Of the remaining transcripts, 60 (22.2%) were unique to the diploid population and 47 (17.4%) were unique to the tetraploid population.
All transcripts encoding known proteins were next categorized functionally using PANTHER ontology software (Thomas et al., 2003) . A total of 42% of the functions attributable to the 163 common transcripts involved processes pertaining to metabolism, signal transduction, immunity and defense, and translational control/protein stability (Supplementary Figure 3b) . A comparison of functional categories showed diploid Rat1a-GpIba cells to be enriched for transcripts involved in cell proliferation and differentiation (5 vs 1% in tetraploid cells), cell cycle control (7 vs 1%) and transcriptional regulation (7 vs 3%), whereas tetraploid Rat1a-Gpiba cells were enriched for transcripts involved in transport (8 vs 1%) and immunity and defense (11 vs 5%).
Increased expression of GpIba in cancer
Although many established and primary cell types express GpIba , its relationship to human cancers is unclear. To address this in light of our current findings, we evaluated GpIba and c-Myc protein levels in a panel of transformed and normal cell types. As shown in Figure 6a , GpIba was detected in all cases, with the highest levels occurring in cancer lines. Consistent with our previous report (Rogulski et al., 2005b) , a notable correlation between c-Myc and GpIba expression was seen (Figure 6b ). Finally, a search of the Oncomine database (http://www.oncomine.org; Rhodes et al., 2004) indicated that GpIba transcripts were overexpressed in germ cell tumors vs normal testicular tissue (P ¼ 0.001; Korkola et al., 2006) , in imatinibresistant chronic myelogenous leukemia vs untreated chronic-phase disease (P ¼ 7 Â 10
À7
; Radich et al., 2006; Figure 6c) , and in c-src-transformed primary human mammary epithelial cells (Bild et al., 2006) .
Discussion
The association between c-Myc and ploidy in mammals (Li and Dang, 1999; Yin et al., 1999) may relate to the function of the Drosophila c-Myc ortholog, dMyc. In larval tissues destined to undergo endoreplication, hypomorphic variants of dMyc impart a profound endoreduplicative defect (Maines et al., 2004; Pierce et al., 2004) . However, the mechanism(s) by which Drosophila and mammalian Myc proteins promote endoreduplication vs cancer cell aneuploidy, respectively, remain ill defined. Recently, we showed that MT-MC1 activates a novel pathway through which aberrantly expressed c-Myc promotes endomitosis (Rogulski et al., 2005a, b; Li et al., 2007) . In contrast to c-Myc, MT-MC1 deregulates o50 genes, including GpIba.
GpIba has been previously thought to be restricted to the megakaryocytic lineage (Canobbio et al., 2004) , where, as a vWFR subunit, it participates in hemostasis and endomitosis (Lopez and Dong, 1997; Feng et al., 1999; Kanaji et al., 2004) . However, as shown here, GpIba is not only widely expressed but is a classical oncoprotein by virtue of its ability to transform, promote growth and inhibit apoptosis in established cell lines, and to induce p53-dependent senescence in primary cells. That GpIba-expressing cells can be maintained in different states of ploidy provides an Transformation by GpIba Y Li et al opportunity to assess how chromosomal content contributes to transformation (Andreassen et al., 2003; Weaver and Cleveland, 2006) .
The main consequence of tetraploidy appeared to be in the in vivo context where it conferred a distinct growth advantage (Figure 1e ). These tumors, along with in vitro maintained cells, eventually reacquired apparently diploid genomes (Figures 2b and c) , suggesting that long-term tetraploidy is actually detrimental (Andalis et al., 2004; Comai, 2005; Storchova et al., 2006) . Our finding that (c) The Oncomine database was queried for DNA microarray studies documenting the overexpression of GpIba in primary human tumor samples. The search produced evidence for GpIba overexpression in germ cell tumors vs normal testes (n ¼ 91 and 6 samples, respectively) and in imatinib-resistant, relapsed chronic-phase chronic myeloid leukemia (CML) vs untreated stable-phase disease (n ¼ 104 and 15 samples, respectively). Note also the elevated levels of GpIba transcripts in human mammary gland epithelial cells transformed by c-src (Bild et al., 2006) . P-values indicate the probability that the measured differences were chance occurrences. Bars represent the 25-75% interval of normalized expression in each group, lines represent the 10-90% interval and dots represent the maximum and minimum levels of expression.
Transformation by GpIba Y Li et al diploid cells derived from initially tetraploid tumors are more tumorigenic argues that tetraploidy simply facilitates the acquisition of more subtle growth-promoting mutations (Figure 2h ). Once acquired, these are selected for during in vivo propagation whereas any vestigial tetraploidy is eventually discarded. This model implies that revertant tetraploid-diploid cells are inherently different from the starting diploid population in a manner that escapes detection by crude assessments of ploidy such as flow cytometry. The additional ability of GpIba to induce nuclear and chromatin abnormalities and DSBs (Figures 4i and 5a ), as well as other possible genomic abnormalities attributable to c-Myc overexpression (Neiman et al., 2006; Prochownik and Li, 2007) is also consistent with this model. While the relative contribution of each form of DNA damage is unknown, clear relationships exist among defects in DSB repair, cell cycle checkpoints and aneuploidy (Iarmarcovai et al., 2006) . Comparing the growth, senescence and DNA damage profiles of established and primary cells implicate p53 and pRb in the response to GpIba overexpression (Figure 4 ). Interpreting these results in the context of previous studies suggests that GpIba induces hyperproliferative signals leading to DNA damage and senescence (Kops et al., 2005; Bartkova et al., 2006; Di Micco et al., 2006) . Absent p53, such signals can drive aberrant DNA synthesis, resulting in the acquisition of a tetraploid/aneuploid genome. Independent of this, DSBs may produce dysmorphic nuclei, micronuclei and chromosomal bridging ( Figure 5 ; Supplementary  Figure 2 ). Chromosomal bridging in fission yeast is a consequence of compromised kinetochore function (Ekwall et al., 1999) whereas in mammalian cells, it may arise from telomere defects, abnormalities in DNA replication and/or recombination, translocations associated with bi-centromeric chromosomes or overexpression of mitotic checkpoint genes (Harley and Villeponteau, 1995; Menssen et al., 2007; Sotillo et al., 2007) . Chromosomal bridging has also been implicated in the creation of micronuclei similar to those reported here ( Figure 5 ; Saunders et al., 2000) and leads to other structural and numerical abnormalities (Saunders, 2003) . Together with previous studies showing that inhibition of cytokinesis in p53À/À mammary epithelial cells leads to the appearance of bi-nucleated cells that are structurally indistinguishable from those of p53 þ / þ cells (Fujiwara et al., 2005) , our current findings argue that p53 serves to inhibit or eliminate cells whose genomes have been altered as a result of GpIba overexpression.
The remarkably high level of DSBs in HFF-GpIba cells (Figure 4 ) is consistent with their elevated levels of p53 and differs somewhat from the situation in yeast where DSBs are increased only in tetraploids exposed to exogenous stress (Storchova et al., 2006) . Genotoxicity in GpIba overexpressing cells could also arise as a direct result of tetraploidy and/or from dysmorphic nuclear changes (Figures 4 and 5) . DSBs, by virtue of their tendency to be repaired through nonhomologous endjoining, could generate translocations and perhaps some of the nuclear abnormalities we have observed (Weinstock et al., 2006) . Transcriptional profiling showed that 107 genes were differentially expressed between diploid and tetraploid Rat1a-GpIba cells. Although it seems likely that this group plays a role in promoting, maintaining or responding to tetraploidy, it was notable for its lack of genes functioning in homologous recombination, sister chromatid cohesion or mitotic spindle function, which are implicated in the survival of yeast tetraploids and in the assembly of Drosophila mitotic spindles (Storchova et al., 2006; Goshima et al., 2007) . This discrepancy may reflect more the way by which these critical genes were identified than in actual functional differences. In the first case, yeast strains bearing defined gene deletions were tested for their ability to survive as tetraploids whereas in the second case, genome-wide RNAi was used to suppress genes necessary for mitotic spindle assembly. Because many of the encoded proteins identified by both studies are normally regulated posttranslationally, they might not have registered in the gene expression studies described here (Thorpe et al., 2007) .
In summary, GpIba possesses unique properties entirely unrelated to its previously described function as a subunit of the vWFR. It remains to be determined whether these properties require GpIba's association with other vWFR subunits and how transforming and GI-promoting signals are transmitted.
Materials and methods
Cell culture
Rat1a and primary human foreskin fibroblasts (ATCC, Manassas, VA, USA) and 32D cells were propagated as described (Rogulski et al., 2005a) . All reagents were from Gibco-BRL (Grand Island, NY, USA) unless otherwise stated. Soft agar clonogenicity assays were performed as previously described (Yin et al., 2002) .
Cell cycle analysis
Cell cycle analyses were performed on propidium iodidestained nuclei using a FACSstar flow cytometer (BectonDickinson Biosciences, San Jose, CA, USA). Data were analysed by single-histogram statistics (Rothermund et al., 2005) . G 2 /M arrest was achieved by incubating cells in the presence of colcemid (25-35 ng ml
À1
, Sigma-Aldrich, St Louis, MO, USA) for 16-20 h.
In vivo tumorigenesis assays Athymic nu/nu mice (4-6 weeks old) were purchased from Harlan Sprague-Dawley (Indianapolis, IN, USA). Tumorigenicity assays and tumor volume measurements were performed as previously described (Yin et al., 2002) and as outlined in Supplementary Materials and methods.
Recombinant DNA methods
The pLXSN-EYFP retroviral vector that allows expression of myc epitope-tagged GpIba has been previously described . The pRetroSuper-shp53 plasmid was a gift from Dr Reuven Agami (Brummelkamp et al., 2002) .
Western blots, immunohistochemistry and fluorescence microscopy All procedures are described in Supplementary Materials and methods.
DNA microarrays
Isolation of RNA was performed as described (Nesbit et al., 2000) . Preparation of biotinylated RNA (cRNA) was performed by the PittArray DNA Microarray Facility of the Genomics and Proteomics Core Laboratories at the University of Pittsburgh Medical Center. cRNAs were hybridized overnight to triplicate Affymetrix Rat Genome 230 2.0 GeneChips (Affymetrix, Santa Clara, CA, USA) and analysed using Affymetrix GeneChip Operating Software version 1.4 and dChip version 1.3 software (see Supplementary Materials and methods).
